Stay updated on ELVN-002 in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.

Latest updates to the ELVN-002 in HER2 NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant updates regarding the clinical trial for ELVN-002, including a new version revision and changes to the trial's structure and patient criteria. Key details about the trial's phases and objectives have been added, while previous descriptions have been removed.SummaryDifference25%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 9, 2025, while a date of March 25, 2025, has been removed.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a more recent last update date (2025-03-25), replacing the previous version (v2.14.2) and its date (2025-01-09).SummaryDifference0.2%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to ELVN-002 in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ELVN-002 in HER2 NSCLC Clinical Trial page.